Pharmaceutical company internet sites as sources of information about antidepressant medications

CNS Drugs

Volumn 16, Issue 6, 2002, Pages 419-423

  Graber, Mark A ^a   Weckmann, Michelle ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADVERTIZING; ARTICLE; DATA BASE; DEPRESSION; DRUG CHOICE; DRUG INDUSTRY; DRUG INFORMATION; HUMAN; INTERNET; PRIORITY JOURNAL;

EID: 0036278936     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200216060-00005     Document Type: Article

References (28)

1. The educational value of consumer-targeted prescription drug print advertising
2. Addressing the problem of misleading advertising
3. Direct-to-consumer marketing of prescription drugs: Creating consumer demand
4. Drug companies' evidence to justify advertising
5. Drug advertising: Is this good medicine?
6. Quality of web based information on tre atment of depression: Cross sectional survey
7. Readability level, learning presentation preference, and desire for information among cancer patients
8. Reading ability of parents compared with readability level of pediatric patient education materials
9. Measuring patients' ability to read and comprehend: A first step in patient education
10. Patient's understanding of health information: A multihospital comparison
11. Trends in antihypertensive drug use in the United States: Do the JNC V recommendations affect prescribing?
12. Consumer, heal thyself: Ads for prescription drugs are popping up more frequently in consumer media
13. Advertisement-induced prescription drug requests: Patients' anticipated reactions to a physician who refuses
14. Doctors feel the pressure from direct to consumer advertising
15. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians
16. Influence of patient information leaflets on anticonvulsant drug compliance in prison
17. Effects of self medication programme on knowledge of drugs and compliance with treatment in elderly patients
18. Group education sessions and compliance with nasal CPAP therapy
19. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications
20. Failure of educational videotapes to improve medication compliance in a health maintenance organization